Percutaneous Coronary Intervention for Left Main Coronary Artery Disease: Present Status and Future Perspectives.

ABSTRACT: For several decades, coronary artery bypass grafting has been regarded as the standard choice of revascularization for significant left main coronary artery (LMCA) disease. However, in conjunction with remarkable advancement of device technology and adjunctive pharmacology, percutaneous coronary intervention (PCI) offers a more expeditious approach with rapid recovery and is a safe and effective alternative in appropriately selected patients with LMCA disease. Several landmark randomized clinical trials showed that PCI with drug-eluting stents for LMCA disease is a safe option with similar long-term survival rates to coronary artery bypass grafting surgery, especially in those with low and intermediate anatomic risk. Although it is expected that the updated evidence from recent randomized

SUBMITTER: Park S 

PROVIDER: S-EPMC9627854 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature